Product Information
DRONABINOL 2.5 MG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $1.6133 per EA under NDC 31722096060. Its NADAC has been published 292 times since Jun 3, 2020.
FDA first approved this application on Feb 7, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722096060
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
10/22/2025
Active Ingredients
DRONABINOLApproval Type
Generic (ANDA)
FDA Application
ANDA207421FDA Approved
2/7/2020
TE Code
AB
On Market Since
2/10/2020
Pharmacological Classes
Price Statistics
The NADAC for DRONABINOL 2.5 MG CAPSULE has been published 292 times since Jun 3, 2020, and over the history we have for it it has risen 40.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6133 per EA |
|---|---|
| All-time high | $1.7366 (May 14, 2025) |
| All-time low | $0.9537 (Sep 21, 2022) |
| 52-week high | $1.6363 |
| 52-week low | $1.6133 |
| Median price | $1.3178 |
| Average price | $1.3577 |
| Largest weekly change | -29.1% (Sep 21, 2022) |
| Weeks tracked | 292 |
| Tracking since | Jun 3, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-1.4%
3Y
+24.4%
5Y
+31.9%
All
+40.7%
Last surveyed Dec 31, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dronabinol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dronabinol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cannabinoid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DRONABINOL 2.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DRONABINOL 2.5 MG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $1.6133 per EA (NDC 31722096060), effective Dec 31, 2025.
How has the price of DRONABINOL 2.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DRONABINOL 2.5 MG CAPSULE has risen 40.7%. It has been tracked across 292 weekly CMS publications since Jun 3, 2020.
What are the highest and lowest recorded NADAC prices for DRONABINOL 2.5 MG CAPSULE?
Since Jun 3, 2020, the NADAC for DRONABINOL 2.5 MG CAPSULE has ranged from a low of $0.9537 (Sep 21, 2022) to a high of $1.7366 (May 14, 2025), with a median of $1.3178 per EA.
Are there cheaper alternatives to DRONABINOL 2.5 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of DRONABINOL 2.5 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DRONABINOL 2.5 MG CAPSULE?
DRONABINOL 2.5 MG CAPSULE (NDC 31722096060) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.